256 related articles for article (PubMed ID: 667838)
21. A dominated and resistant subpopulation causes regrowth after response to 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of a heterogeneous small cell lung cancer xenograft in nude mice.
Aabo K; Roed H; Vindeløv LL; Spang-Thomsen M
Cancer Res; 1994 Jun; 54(12):3295-9. PubMed ID: 8205552
[TBL] [Abstract][Full Text] [Related]
22. Response of exponentially growing, stationary-phase, and synchronized cultured human colon carcinoma cells to treatment with nitrosourea derivatives.
Drewinko B; Barlogie B; Freireich EJ
Cancer Res; 1979 Jul; 39(7 Pt 1):2630-6. PubMed ID: 445465
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithine.
Bjerkvig R; Oredsson SM; Marton LJ; Linden M; Deen DF
Cancer Res; 1983 Apr; 43(4):1497-500. PubMed ID: 6403224
[TBL] [Abstract][Full Text] [Related]
24. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.
Hill RP; Stanley JA
Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Schein PS; Bull JM; Doukas D; Hoth D
Cancer Res; 1978 Feb; 38(2):257-60. PubMed ID: 620400
[TBL] [Abstract][Full Text] [Related]
26. DNA cross-linking by in vivo treatment with 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of sensitive and resistant human colon carcinoma xenograms in nude mice.
Thomas CB; Osieka R; Kohn KW
Cancer Res; 1978 Aug; 38(8):2448-54. PubMed ID: 667842
[TBL] [Abstract][Full Text] [Related]
27. Factors influencing the survival of rat brain tumor cells after in vitro treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Wheeler KT; Tel N; Williams ME; Sheppard S; Levin VA; Kabra PM
Cancer Res; 1975 Jun; 35(6):1464-9. PubMed ID: 1169107
[TBL] [Abstract][Full Text] [Related]
28. Effects of alpha-difluoromethylornithine on the growth of 9L rat brain tumor multicellular spheroids and their response to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Sano Y; Deen DF; Oredsson SM; Marton LJ
Cancer Res; 1984 Feb; 44(2):577-81. PubMed ID: 6420048
[TBL] [Abstract][Full Text] [Related]
29. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
30. Chemosensitization of cultured human carcinoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by difluoromethylornithine-induced polyamine depletion.
Seidenfeld J; Komar KA
Cancer Res; 1985 May; 45(5):2132-8. PubMed ID: 3921237
[TBL] [Abstract][Full Text] [Related]
31. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
Aida T; Bodell WJ
No To Shinkei; 1987 Mar; 39(3):235-41. PubMed ID: 3472531
[TBL] [Abstract][Full Text] [Related]
32. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Einstein AB; Fass L; Fefer A
Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity and DNA damaging effects of a new nitrosourea, fotemustine, diethyl- 1-(3-(2-chloroethyl)-3-nitrosoureido) ethylphosphonate-S10036.
Tapiero H; Yin MB; Catalin J; Paraire M; Deloffre P; Rustum Y; Bizzari JP; Tew KD
Anticancer Res; 1989; 9(6):1617-22. PubMed ID: 2627116
[TBL] [Abstract][Full Text] [Related]
34. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
Hill HZ; Hill GJ
Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
[TBL] [Abstract][Full Text] [Related]
35. Studies on recovery from chemically induced damage in mammalian cells.
Barranco SC; Novak JK; Humphrey RM
Cancer Res; 1975 May; 35(5):1194-204. PubMed ID: 47265
[TBL] [Abstract][Full Text] [Related]
36. Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
Tofilon PJ; Basic I; Milas L
Cancer Res; 1985 May; 45(5):2025-30. PubMed ID: 4039220
[TBL] [Abstract][Full Text] [Related]
37. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
38. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
Teicher BA; Holden SA; Eder JP; Brann TW; Jones SM; Frei E
Cancer Res; 1989 Nov; 49(21):5994-8. PubMed ID: 2790813
[TBL] [Abstract][Full Text] [Related]
39. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
Mulcahy RT; Dembs N
Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127
[TBL] [Abstract][Full Text] [Related]
40. Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
August EM; Prusoff WH
Cancer Res; 1988 Aug; 48(15):4272-5. PubMed ID: 3390823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
